Since ICOS engagement promotes ALK+ ALCL proliferation, it is tempting to speculate that by engaging its ligand (ICOS-L), tumor-specific ICOS subverts other critical co-stimulatory signals from immune cells, impairing cytotoxic response to tumor cells. Here, ICOS is linked to neoplasm.